William Woods
Stock Analyst at B. Riley Securities
(1.58)
# 3,445
Out of 5,182 analysts
15
Total ratings
43.75%
Success rate
-3.84%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EQ Equillium | Initiates: Buy | $6 | $2.08 | +188.46% | 1 | Apr 16, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $7 → $8 | $4.11 | +94.65% | 2 | Mar 13, 2026 | |
| ALT Altimmune | Maintains: Buy | $18 → $13 | $2.79 | +365.95% | 1 | Mar 6, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $7 | $1.98 | +254.43% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $524.17 | +27.82% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.58 | +216.46% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.26 | +138.11% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $4.50 | +122.22% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $60 → $50 | $9.80 | +410.20% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.33 | +2,045.92% | 1 | May 14, 2024 |
Equillium
Apr 16, 2026
Initiates: Buy
Price Target: $6
Current: $2.08
Upside: +188.46%
KORU Medical Systems
Mar 13, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $4.11
Upside: +94.65%
Altimmune
Mar 6, 2026
Maintains: Buy
Price Target: $18 → $13
Current: $2.79
Upside: +365.95%
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.98
Upside: +254.43%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $524.17
Upside: +27.82%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.58
Upside: +216.46%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.26
Upside: +138.11%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.50
Upside: +122.22%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $60 → $50
Current: $9.80
Upside: +410.20%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.33
Upside: +2,045.92%